within Pharmacolibrary.Drugs.ATC.J;

model J01MB08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.89,
    Cl             = 7.53 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.09309999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Nemonoxacin is a non-fluorinated quinolone antibiotic, used for the treatment of community-acquired pneumonia and other infections caused by susceptible bacteria. It is approved for clinical use in certain countries primarily in Asia.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Guo, B, et al., &amp; Zhang, J (2012). Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses. <i>Clinical drug investigation</i> 32(7) 475–486. DOI:<a href=&quot;https://doi.org/10.2165/11632780-000000000-00000&quot;>10.2165/11632780-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22650326/&quot;>https://pubmed.ncbi.nlm.nih.gov/22650326</a></p></li><li><p>Zhao, C, et al., &amp; Tian, J (2018). Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults. <i>Clinical therapeutics</i> 40(6) 983–992. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2018.04.014&quot;>10.1016/j.clinthera.2018.04.014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29803534/&quot;>https://pubmed.ncbi.nlm.nih.gov/29803534</a></p></li><li><p>Zhang, YF, et al., &amp; Zhong, DF (2014). Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers. <i>Acta pharmacologica Sinica</i> 35(12) 1586–1592. DOI:<a href=&quot;https://doi.org/10.1038/aps.2014.95&quot;>10.1038/aps.2014.95</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25327812/&quot;>https://pubmed.ncbi.nlm.nih.gov/25327812</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01MB08;
